Goldberg D, Gardiner E, Morrison N A, Eisman J A
Bone and Mineral Research Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, New South Wales, Australia.
J Cell Biochem. 1995 Aug;58(4):499-508. doi: 10.1002/jcb.240580413.
Sequential activation of cell type-specific genes occurs during osteoblast development. The promoter of one such gene, osteocalcin, has been widely studied, but the DNA sequences that govern osteoblast-specific expression have not been defined. The proximal osteocalcin promoter linked to pTKCAT directs strong promoter activity in osteoblast-like ROS17/2.8 cells and comparatively weak promoter activity in nonosteoblastic NIH3T3 cells. To identify sequences important in conferring cell-specific expression of the osteocalcin gene, a deletion series of the human proximal promoter was constructed and the activities assessed in ROS17/2.8 and NIH3T3 cells. These studies identified a 30 bp sequence within the proximal promoter (osteocalcin repressor element-1 [ORE-1]) which is responsible for repressing the transcriptional activity in NIH3T3 cells. In electrophoretic mobility shift assays from both NIH3T3 and ROS17/2.8 cells, a protein complex bound to the ORE-1 that was related to a complex which binds the G/C-rich repressor element in the collagen type I (alpha 1) promoter. In addition, there was a second complex from NIH3T3 cells but not ROS17/2.8 cells that bound the ORE-1 fragment. The presence of this additional factor in NIH3T3 cells parallels the observation that constructs carrying the ORE-1 sequence have repressed promoter activity relative to the analogous constructs lacking the ORE-1 when transfected into NIH3T3 and suggests that the NIH3T3-specific factor is a repressor. These data indicate that the G/C element in the ORE-1 contributes to the repression of osteocalcin gene transcription in a nonosteoblast cell line. The high homology between the ORE-1 sequence and a related sequence in the collagen type I (alpha 2) proximal promoter suggests that homologous regions in other osteoblast-expressed genes may function similarly.
在成骨细胞发育过程中会发生细胞类型特异性基因的顺序激活。其中一个这样的基因——骨钙素的启动子已被广泛研究,但调控成骨细胞特异性表达的DNA序列尚未明确。与pTKCAT相连的近端骨钙素启动子在成骨样ROS17/2.8细胞中具有很强的启动子活性,而在非成骨的NIH3T3细胞中启动子活性相对较弱。为了鉴定赋予骨钙素基因细胞特异性表达的重要序列,构建了人近端启动子的缺失系列,并在ROS17/2.8和NIH3T3细胞中评估其活性。这些研究在近端启动子内鉴定出一个30 bp的序列(骨钙素抑制元件-1 [ORE-1]),它负责抑制NIH3T3细胞中的转录活性。在来自NIH3T3和ROS17/2.8细胞的电泳迁移率变动分析中,一种蛋白质复合物与ORE-1结合,该复合物与结合I型胶原(α1)启动子中富含G/C的抑制元件的复合物相关。此外,来自NIH3T3细胞而非ROS17/2.8细胞的第二种复合物与ORE-1片段结合。NIH3T3细胞中这种额外因子的存在与以下观察结果一致:当转染到NIH3T3中时,携带ORE-1序列的构建体相对于缺乏ORE-1的类似构建体具有被抑制的启动子活性,这表明NIH3T3特异性因子是一种抑制因子。这些数据表明,ORE-1中的G/C元件有助于在非成骨细胞系中抑制骨钙素基因的转录。ORE-1序列与I型胶原(α2)近端启动子中的相关序列高度同源,这表明其他成骨细胞表达基因中的同源区域可能具有类似的功能。